Metabolic Fate: BPC-157 is primarily metabolized in the liver, where it is broken down into smaller peptide fragments and individual amino acids that enter normal metabolic pathways
The benzyl alcohol preservative prevents bacterial contamination that could degrade the peptide or introduce confounding variables in research assays
The clinical team, licensed physicians and healthcare providers who specialize in hormone therapy, takes a whole-body view of each patient
There is no reliable human data to support efficacy for tendon repair.[3] KPV is a three-amino-acid C-terminal fragment of alpha-melanocyte-stimulating hormone
The determining factor is usually cortisol
April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)